Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000936
Chunk: 67

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 67
---
termination date the Investor holds no Registrable Securities (or, if applicable, the date on which such securities cease to be Registrable
Securities after the date of termination of the Purchase Agreement) (the “”). The effective Registration
Statement (including any amendments or supplements thereto and prospectuses contained therein) shall not contain any untrue statement
of a material fact or omit to state a material fact required to be stated therein, or necessary to make the statements therein, in light
of the circumstances in which they were made, not misleading.

| 2 |

b. . The Company shall, as required by applicable securities regulations, from time to time file with the SEC, pursuant
to Rule 424 promulgated under the Securities Act, the prospectus and prospectus supplements, if any, to be used in connection with sales
of the Registrable Securities under the Registration Statement. The Investor and its counsel shall have a reasonable opportunity to review
and comment upon such prospectus prior to its filing with the SEC, and the Company shall give due consideration to all such comments.
The Investor shall use its commercially reasonable efforts to comment upon such prospectus within one (1) Business Day from the date the
Investor receives the substantially final pre-filing version of such prospectus.

c. . In the event the number of Depositary Shares available under the Registration Statement is insufficient
to cover all of the Registrable Securities, the Company shall, to the extent necessary and permissible, amend the Registration Statement
or file a new Registration Statement (a “”), so as to cover all of such Registrable Securities
(subject to the limitations set forth in ) as soon as reasonably practicable, but in any event not later than ten (10)
Business Days after the necessity therefor arises, subject to any limits that may be imposed by the SEC pursuant to Rule 415 under the
Securities Act. The Company shall use its commercially reasonable efforts to cause such amendment and/or New Registration Statement to
become effective as soon as reasonably practicable following the filing thereof.

d. .
If the staff of the SEC (the “”) or the SEC seeks to characterize any offering pursuant to a Registration Statement
filed pursuant to this Agreement as constituting an offering of securities that does not permit such Registration Statement to become
effective and be used for resales by the Investor under Rule 415 at then-prevailing market prices (and not fixed prices), or if after
the filing of the initial Registration Statement with the SEC pursuant to , the Company is